About this trial
Abdominal aortic aneurysm, a condition characterised by an increase in the diameter of the aorta, can be treated either surgically or endovascularly. In the latter, an endoprosthesis consisting of a metal spring covered with an impermeable fabric is inserted through an artery and deployed inside the aorta. This new method appears to be less invasive than surgery, but its long-term results are not yet fully understood. As a result, patients who have undergone this treatment are monitored by their surgeon to ensure that there is no endoleak. Several research teams have proposed analysing medical images to predict this risk of endoleak. Doctors are now trying to use artificial intelligence to automate the analysis of these images.
Eligibility criteria
Qualifiers
Treated for an abdominal aortic aneurysm through endovascular prosthesis implantation
Disqualifiers
Underwent intraoperative embolization of the inferior mesenteric artery or aneurysmal sac
Refuse the use of their data
Trial design
Treatments tested in this trial
- Abdominal aortic endoprosthesis
Treatment groups
Sponsors and collaborators
Groupe Hospitalier de la Rochelle Ré Aunis
Lead sponsor
La Rochelle University
Collaborator